BACKGROUND: Selenium, a potential cancer prevention agent currently being tested against prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT), plays an integral role in thyroid metabolism. The effects of long-term selenium supplementation on thyroid hormone concentrations are unknown. OBJECTIVE: The objective was to investigate the effects of long-term selenium supplementation on thyroid hormone concentrations. DESIGN: Twenty-eight healthy adults took 200 microg selenomethionine/d for 28 mo. The thyroid hormones triiodothyronine (T3), thyroxine (T4), and thyrotropin (TSH) were measured in plasma for 4 mo before supplementation and quarterly during supplementation. The assay methods were changed midstudy; the results of the 2 methods were not comparable. Therefore, one analysis was conducted based on the results of the first method, and a second analysis was based on all of the data, adjusted for the change. Serial data collection permitted a test for trends rather than simply a difference between initial and final values. RESULTS: By 9 mo, mean (+/-SEM) plasma selenium concentrations had increased from 1.78 +/- 0.07 micromol/L at baseline to 2.85 +/- 0.11 micromol/L for men and from 1.64 +/- 0.04 to 3.32 +/- 0.1.2 micromol/L for women. T3 concentrations in men increased 5% per year (P = 0.01). T4 and TSH concentrations were unchanged. CONCLUSIONS: Selenium supplementation produced no clinically significant changes in thyroid hormone concentrations. A small but statistically significant increase in T3 concentrations was noted in men, with no corresponding decreases in TSH. A subset of SELECT subjects might be monitored periodically for changes during long-term selenium supplementation.
BACKGROUND:Selenium, a potential cancer prevention agent currently being tested against prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT), plays an integral role in thyroid metabolism. The effects of long-term selenium supplementation on thyroid hormone concentrations are unknown. OBJECTIVE: The objective was to investigate the effects of long-term selenium supplementation on thyroid hormone concentrations. DESIGN: Twenty-eight healthy adults took 200 microg selenomethionine/d for 28 mo. The thyroid hormones triiodothyronine (T3), thyroxine (T4), and thyrotropin (TSH) were measured in plasma for 4 mo before supplementation and quarterly during supplementation. The assay methods were changed midstudy; the results of the 2 methods were not comparable. Therefore, one analysis was conducted based on the results of the first method, and a second analysis was based on all of the data, adjusted for the change. Serial data collection permitted a test for trends rather than simply a difference between initial and final values. RESULTS: By 9 mo, mean (+/-SEM) plasma selenium concentrations had increased from 1.78 +/- 0.07 micromol/L at baseline to 2.85 +/- 0.11 micromol/L for men and from 1.64 +/- 0.04 to 3.32 +/- 0.1.2 micromol/L for women. T3 concentrations in men increased 5% per year (P = 0.01). T4 and TSH concentrations were unchanged. CONCLUSIONS:Selenium supplementation produced no clinically significant changes in thyroid hormone concentrations. A small but statistically significant increase in T3 concentrations was noted in men, with no corresponding decreases in TSH. A subset of SELECT subjects might be monitored periodically for changes during long-term selenium supplementation.
Authors: J J Strain; E Bokje; P van't Veer; J Coulter; C Stewart; H Logan; W Odling-Smee; R A Spence; K Steele Journal: Nutr Cancer Date: 1997 Impact factor: 2.900
Authors: L C Clark; G F Combs; B W Turnbull; E H Slate; D K Chalker; J Chow; L S Davis; R A Glover; G F Graham; E G Gross; A Krongrad; J L Lesher; H K Park; B B Sanders; C L Smith; J R Taylor Journal: JAMA Date: 1996-12-25 Impact factor: 56.272
Authors: Amanda S Niskar; Daniel C Paschal; Stephanie M Kieszak; Katherine M Flegal; Barbara Bowman; Elaine W Gunter; James L Pirkle; Carol Rubin; Eric J Sampson; Michael McGeehin Journal: Biol Trace Elem Res Date: 2003-01 Impact factor: 3.738
Authors: Anna E Voudouri; Stella E Chadio; John G Menegatos; George P Zervas; Fergus Nicol; John R Arthur Journal: Biol Trace Elem Res Date: 2003-09 Impact factor: 3.738
Authors: M R Calomme; J B Vanderpas; B François; M Van Caillie-Bertrand; A Herchuelz; N Vanovervelt; C Van Hoorebeke; D A Vanden Berghe Journal: Experientia Date: 1995-12-18
Authors: Margaret P Rayman; Alexander J Thompson; Bram Bekaert; Janet Catterick; Rachel Galassini; Emma Hall; Margaret Warren-Perry; Geoffrey J Beckett Journal: Am J Clin Nutr Date: 2008-02 Impact factor: 7.045
Authors: Meryl E Wastney; Gerald F Combs; Wesley K Canfield; Philip R Taylor; Kristine Y Patterson; A David Hill; James E Moler; Blossom H Patterson Journal: J Nutr Date: 2011-02-02 Impact factor: 4.798
Authors: Olga Parshukova; Natalya Potolitsyna; Vera Shadrina; Aleksei Chernykh; Evgeny Bojko Journal: Int Arch Occup Environ Health Date: 2013-07-31 Impact factor: 3.015
Authors: Maia J Benner; Matt L Settles; Gordon K Murdoch; Ronald W Hardy; Barrie D Robison Journal: Physiol Genomics Date: 2013-06-04 Impact factor: 3.107
Authors: Roberta F Carvalho; Grazielle V B Huguenin; Ronir R Luiz; Annie S B Moreira; Glaucia M M Oliveira; Glorimar Rosa Journal: Nutr J Date: 2015-06-16 Impact factor: 3.271